company background image
DSM2 logo

DSM-Firmenich DB:DSM2 Stock Report

Last Price

US$113.95

Market Cap

US$0

7D

0.3%

1Y

-28.1%

Updated

31 May, 2023

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DSM2 Stock Overview

DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.

DSM2 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends4/6

DSM-Firmenich AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DSM-Firmenich
Historical stock prices
Current Share PriceUS$113.95
52 Week HighUS$157.30
52 Week LowUS$106.00
Beta0.72
1 Month Change-3.14%
3 Month Change-3.06%
1 Year Change-28.11%
3 Year Change-3.76%
5 Year Change28.73%
Change since IPO105.32%

Recent News & Updates

Recent updates

Shareholder Returns

DSM2 Chemicals Market
7D0.3%0%0%
1Y-28.1%0%0%

Return vs Industry: DSM2 underperformed the German Chemicals industry which returned -12.6% over the past year.

Return vs Market: DSM2 underperformed the German Market which returned -8.2% over the past year.

Price Volatility

Is DSM2's price volatile compared to industry and market?
DSM2 volatility
DSM2 Average Weekly Movement3.4%
Chemicals Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in DE Market0%
10% least volatile stocks in DE Market0%

Stable Share Price: DSM2 has not had significant price volatility in the past 3 months.

Volatility Over Time: DSM2's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190219,973Dimitri de Vreezehttps://www.dsm-firmenich.com

DSM-Firmenich AG Fundamentals Summary

How do DSM-Firmenich's earnings and revenue compare to its market cap?
DSM2 fundamental statistics
Market capn/a
Earnings (TTM)0
Revenue (TTM)n/a

1.7x

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DSM2 income statement (TTM)
RevenueUS$8.39b
Cost of RevenueUS$5.70b
Gross ProfitUS$2.69b
Other ExpensesUS$2.24b
EarningsUS$454.00m

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)67.80
Gross Margin32.06%
Net Profit Margin5.41%
Debt/Equity Ratio26.6%

How did DSM2 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.